Stay updated on Frailty-guided Dosing in Myeloma Clinical Trial
Sign up to get notified when there's something new on the Frailty-guided Dosing in Myeloma Clinical Trial page.

Latest updates to the Frailty-guided Dosing in Myeloma Clinical Trial page
- Check3 days agoChange DetectedThe Record History page now lists revision v3.5.3, replacing the previous v3.5.2. This indicates a minor update to the page's revision history.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedA new history entry, Revision: v3.5.2, was added. The older entry, Revision: v3.5.0, was removed.SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check46 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0 on the page.SummaryDifference0.1%

- Check53 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check82 days agoChange DetectedAdded Revision: v3.4.2 and removed Revision: v3.4.1 along with a lapse-in-government-funding notice; these are routine page-history updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check89 days agoChange DetectedAdded a site-wide notice about government funding and operating status, and introduced a new revision tag (v3.4.1) while removing the previous tag (v3.4.0).SummaryDifference0.8%

Stay in the know with updates to Frailty-guided Dosing in Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Frailty-guided Dosing in Myeloma Clinical Trial page.